Kuwait Retail Pharmacy Market is Expected to Reach about KD 600 Million in Terms of Revenue by 2022: Ken Research

• Rising population in Kuwait due to surge in life expectancy and shift in the demographic pattern leading to a increase in ageing population and is expected to drive retail pharmacy market in the country.
• This widespread prevalence of NCDs and chronic diseases in Kuwait, such as heart disease, cancer and diabetes, and changing dietary habits will led to increase in the demand of retail pharmacies in the country.
• Increasing demand of private label goods in country will lead to surge in the demand of medicated cosmetics and food supplements in the country which will positively increase the revenue of retail pharmacies.

Rising Obese Population: In Kuwait, obesity is one of the major causes of various diseases such as kidney disease, diabetes, cardiovascular diseases, hypertension, cholesterol and musculoskeletal disorders. It has been observed in the year 2016, obesity - adult prevalence rate in Kuwait was approximately 37.9%. In addition to this, it has been observed that in Kuwait, approximately 5,000 stomach stapling’s performed every year. In future, it is expected that obese children would act as potential patients for healthcare professionals as they suffer from chronic diseases such as type-2 diabetes, hypertension and chronic kidney disease due to overweight, which will generate high revenue for the retail pharmacy market.

Increasing Government Expenditure on Health Care Sector: In 2010, the Kuwait Government has launched its KD 30 billion NDP (National Development Plan) programe. One of the most important objective of the plan was to modernise and reform the health care system and health infrastructure in the country to meet the needs of the increasing population, and address a sudden and significant growth in NCDs (Non-Communicable Disease). The government has allocated funds to improve the healthcare infrastructure by opeining of new speciality hospitals in the country. For instance: In the year 2017, Kuwait government has spent USD 5.9 billion on healthcare sector, with an increase of 3.7% during the period 2013-2017. This further acted as a key growth factor for retail pharmacy and is projected to play an important role in dealing with the country’s projected future healthcare requirements.

Increasing Sale of Private Label Goods: Private label goods majorly consists of cosmetics and food supplements (vitamins) which accounted a major share in generating revenue for pharmacy stores in Kuwait. In 2017, private label goods contributed 75.0% share as Kuwait has high expatriate population and majority of the expat population is health conscious which led to an increase in the demand of medicinal cosmetic from retail pharmacies. On the other hand, introduction of first five year plan namely Kuwait National Programme for healthy living (2013-2017) has further motivated the people to perform daily exercise which augmented the demand of health supplements among people to stay fit.

Analysts at Ken Research in their latest publication “Kuwait Retail Pharmacy Market Outlook to 2022 - By Type of Pharmacy (Pharmacy Chains, Independent Pharmacies and Hospital/Clinic Based Pharmacies); By Type of Drugs (Cosmetics, Food Supplements and Drugs), and By Type of Sales Channels (Offline and Online)” believe that the Retail Pharmacy Market in Kuwait has been growing and is expected that it will expand further due to adoption of medication therapy management, data integration to achieve optimum customer satisfaction and by improving E-commerce platform for retail pharmacy sales.

The market is expected to register a positive CAGR of 7.7% in terms of revenue during the forecast period 2017-2022. The market is further expected to be driven by the increasing competition from new companies entering the market.

For more information about the report, refer to below link:
https://www.kenresearch.com/healthcare/pharmaceuticals/kuwait-retail-pharmacy-market/175024-91.html

Key Segments Covered
• Market Segmentation
 By Type of Pharmacy (Pharmacy Chains, Independent Pharmacies and Hospital/Clinic Based Pharmacies)
 By Type of Drugs (Cosmetics, Food Supplements and Drugs)
 By Revenue Split (KD 500 to KD 2,000, KD 2,000 to KD 4,000 and KD 5,000 to KD 10,000)
 By Type of Sales Channels (Offline and Online)

Key Target Audience
• Hospitals
• Pharmaceutical Manufacturers
• Pharmaceutical Distributors
• Pharmacy Chains
• Health Care Associations

Time Period Captured in the Report:
• Historical Period – 2012-2017
• Forecast Period – 2018-2022

Companies Covered:
• Royal Pharmacy
• Pharmazone
• YIACO
• Ali-Abdulwahab Al-Mutawa
• Boots Pharmacy
• Al-Hajery
• Aster
• Dowa
• PharmaTee

Related Reports:

https://www.kenresearch.com/healthcare/pharmaceuticals/india-pharmacy-stores-market-report/3896-91.html
The report provides information on market size for Indonesia Healthcare and pharmacy retail. The report covers pharmacy retail market segment (by pharmacies & drugstores and by region), value chain, trends, growth drivers, and competitive landscape of major pharmacy retail companies including Guardian Pharmacy, Kimia Farma, Apotek K-24, A S Watsons Group, and Century Healthcare. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

https://www.kenresearch.com/healthcare/pharmaceuticals/india-pharmacy-stores-market-report/3896-91.html
The report provides a comprehensive analysis of the various aspects such as market size of the India Pharmacy Retail and Online Pharmacy Retail Market. The report also covers the market segmentation on the basis of organized & unorganized pharmacies, prescribed drugs, OTC drugs & private label products, category of drugs and generic & patented drugs. The report shares the company profile and competitive landscape for major players in the organized pharmacy sector and online pharmacy market.

https://www.kenresearch.com/healthcare/general-healthcare/qatar-healthcare-market-report/99730-91.html
The report provides a comprehensive analysis of the healthcare market in Qatar. The report focuses on the hospitals and clinics, medical devices used in the hospital setting, diagnostic laboratories, clinics and polyclinics, pharmaceutical drugs and injectable used for treatment and diagnostic purposes, and services provided by healthcare providers. The report covers aspects such as overall healthcare market by its key segments including medical devices, pharmaceuticals, hospitals, independent diagnostic laboratories, clinics/polyclinics, retail pharmacy and their sub-segments. The publication also includes the competitive landscape in each section, which discusses the major market players in every segment along with the detailed discussion about the organization. The future analysis of overall Qatar Healthcare has also been discussed along with recommendations from analyst view. The report also includes information about health insurance in Qatar, regulatory bodies governing healthcare policies in Qatar, regulations which impact healthcare market and procedure to import medical devices and pharmaceuticals in the country.
 
https://www.kenresearch.com/healthcare/pharmaceuticals/vietnam-pharmaceutical-market/143605-91.html
The report provides a comprehensive analysis of Vietnam pharmaceutical market overview and size, growth drivers and restraints. The report also provides data points on Vietnam Pharmaceutical market by Generic and Patented drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory and Others) along with company profiles of DHG Pharma, Traphaco, Pymepharco, Ha Tey Pharmaceutical, Mekophar, Domesco, Imexpharma, OPC, Sanofi, GSK, AstraZeneca, Novartis, Roche, Pfizer, MSD and Bayer. The report also covers government regulations, procedure of how drugs procured in public hospitals, Comparative Analysis of Pharmaceutical Companies, Trade scenario, Analyst Recommendations and future outlook for Vietnam Pharmaceutical Market.

Contact Us:
Ankur Gupta
Ken Research, Head Marketing
Ankur@kenresearch.com
+91-9015378249

Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana - 122001, India

Ken Research is a Global aggregator and publisher of Market intelligence, equity and economy reports. We provides business intelligence and operational advisory in 300+ verticals underscoring disruptive technologies, emerging business models with precedent analysis and success case studies.

This release was published on openPR.